| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2995660 | Journal of Vascular Surgery | 2008 | 11 Pages |
Abstract
The pivotal VALOR 12-month trial results demonstrate that the Medtronic Talent Thoracic Stent Graft System is a safe and effective endovascular therapy as an alternative to open surgery in patients with TAA who were considered candidates for open surgical repair.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ronald M. MD, Frank Criado, Mark MD, Christopher MD, Manish MD, Rodney MD, Anthony MD, J. Michael Tuchek, VALOR Investigators VALOR Investigators,